Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 24.7 USD 1.31%
Market Cap: 9.5B USD

Intrinsic Value

MRNA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MRNA stock under the Base Case scenario is 33.61 USD. Compared to the current market price of 24.7 USD, Moderna Inc is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MRNA Intrinsic Value
33.61 USD
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Moderna Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MRNA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MRNA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Moderna Inc
NASDAQ:MRNA
US
Biotechnology
Market Cap
9.6B USD
IPO
Dec 7, 2018
US
Biotechnology
Market Cap
9.6B USD
IPO
Dec 7, 2018
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Moderna Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Moderna Inc

Current Assets 6.8B
Cash & Short-Term Investments 6B
Receivables 306m
Other Current Assets 485m
Non-Current Assets 5.9B
Long-Term Investments 2.4B
PP&E 3B
Intangibles 101m
Other Non-Current Assets 449m
Efficiency

Free Cash Flow Analysis
Moderna Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Moderna Inc

Revenue
3.2B USD
Cost of Revenue
-995m USD
Gross Profit
2.2B USD
Operating Expenses
-5.4B USD
Operating Income
-3.3B USD
Other Expenses
-91m USD
Net Income
-3.4B USD
Fundamental Scores

MRNA Profitability Score
Profitability Due Diligence

Moderna Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Positive Revenue Growth Forecast
28/100
Profitability
Score

Moderna Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

MRNA Solvency Score
Solvency Due Diligence

Moderna Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
79/100
Solvency
Score

Moderna Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRNA Price Targets Summary
Moderna Inc

Wall Street analysts forecast MRNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRNA is 46.68 USD with a low forecast of 20.2 USD and a high forecast of 207.9 USD.

Lowest
Price Target
20.2 USD
18% Downside
Average
Price Target
46.68 USD
89% Upside
Highest
Price Target
207.9 USD
742% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Moderna Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MRNA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MRNA Insider Trading
Buy and sell transactions by insiders

MRNA News

Other Videos
What is the Intrinsic Value of one MRNA stock?

The intrinsic value of one MRNA stock under the Base Case scenario is 33.61 USD.

Is MRNA stock undervalued or overvalued?

Compared to the current market price of 24.7 USD, Moderna Inc is Undervalued by 27%.

Back to Top